Significantly, single nucleotide polymorphisms (SNPs) of FERMT2 are implicated in both familial Alzheimer's disease (fAD) and late‐onset Alzheimer's disease (LOAD), demonstrating the most pronounced association with stages of mild cognitive impairment [29, 30]. This evidence concerns the gene FERMT2 and familial Alzheimer disease.